Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 324
Immune Disorders Drugs 213
Biopharmaceuticals 186
Musculoskeletal Disorders Drugs 126
Drug Discovery 122
Genomics 120
Cardiovascular Drugs 107
Biotechnology 79
Clinical Trials 78
Biosimilars and Biosuperiors 77
Pharmaceuticals 75
Endocrine and Metabolic Disorders Drugs 72
Leukemia Drugs 71
Hematological Drugs 66
Infusions and Injectables 65
Dermatological Drugs 54
Women's Health 51
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 48
Allergy and Immunology 47
Needles and Syringes 47
Diagnostics 41
Skin Cancer Drugs 38
Drug Delivery 35
Psoriasis Drugs 35
Colon Cancer Drugs 34
Oncology 33
Gastrointestinal Drugs 32
Proteomics 29
Infectious Diseases Drugs 28
Immunosuppressive Drugs 27
Brain Cancer Drugs 25
Analgesics 25
Enzymes 25
Hematology 25
Pharmaceutical Manufacturing 25
Lung Cancer Drugs 23
Respiratory Drugs 23
Lymphoma Drugs 22
Kidney Cancer Drugs 18
Drugs by Therapeutic Area 15
Healthcare Services 15
Optical 15
Pancreatic Cancer Drugs 15
Therapeutic Area 14
Optical Disorders Drugs 14
Dermatology 13
Nanomedicine 13
Ovarian Cancer Drugs 12
Sexual and Reproductive Health Drugs 12
E-Healthcare 11
Generic Drugs 11
Urology and Nephrology 10
Prostate Cancer Drugs 10
Cervical Cancer Drugs 10
Other Healthcare Facilities 10
Liver Cancer Drugs 9
Breast Cancer Drugs 9
Cardiology 9
Pulmonary Medicine 8
In Vitro Diagnostics 8
Vaccines 8
Cancer Vaccines 8
Asthma Drugs 8
Biomarkers 7
Company Reports 6
Anti-Obesity Drugs 6
Gastroenterology 6
Diabetes Drugs 5
Biomaterials 5
Medical Devices 5
Molecular Diagnostics 5
Mental Disorders Drugs 5
Animal Pharmaceuticals 4
Pharmaceutical Intermediates 4
Cardiovascular Devices 4
Managed Care 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Laboratory Equipment 4
Pediatrics 4
Alzheimer's Disease Drugs 4
Bladder Cancer Drugs 3
Stem Cells 3
Over the Counter (OTC) Drugs 3
Acne Drugs 3
Schizophrenia Drugs 3
Neurology 2
Pharmacoeconomics 2
Fertility Services 2
Orthopedic Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Uterine Cancer Drugs 2
Clinical Skills 2
Patient Monitoring Equipment 1
Hepatology 1
Bioinformatics 1
Stents 1
Laboratory Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Nuclear Medicine and Radiopharmacology 1
Vitamins and Dietary Supplements 1
Clinical Therapies 1
Antibiotics 1
Palliative Care 1
Anatomy 1
Endocrinology 1
Maternal and Neonatal Care 1
Allergy Drugs 1
Urological Disorders Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



272 reviews

2,091 Results (Page 84 of 105)
- Relevance
  Sort by

Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

 Report
June 2022
89 Pages
Global

From

€1463EUR$1,600USD£1,246GBP

EPO Biomarker Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
109 Pages
Global

From

€3500EUR$4,099USD£3,084GBP

Recombinant DNA Technology Market Report by Product, Component, Application, End User, and Region 2024-2032

 Report
September 2024
139 Pages
Global

From

€2743EUR$2,999USD£2,335GBP

Blood Cancer Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

Anaplastic Astrocytoma Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Targeted Therapy Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1143EUR$1,250USD£973GBP

11 Beta-Hydroxysteroid Dehydrogenase (11ßHSD) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1143EUR$1,250USD£973GBP

Bi-Specific MAbS Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

CAR-T Therapy Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

Gastric Cancer Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

Immuno-Oncology Drugs Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

Oncolytic Virus Therapies Market Report by Virus Type, Application, End Use, and Region 2025-2033

 Report
January 2025
133 Pages
Global

From

€2743EUR$2,999USD£2,335GBP

Gene Therapy Market Report by Gene Type, Vector Type, Delivery Method, Application, and Region 2024-2032

 Report
July 2024
136 Pages
Global

From

€2743EUR$2,999USD£2,335GBP

Dysmenorrhea Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€4545EUR$4,969USD£3,868GBP

Proprotein Convertase Subtilisin/kexin Type 9 Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

 Report
December 2023
300 Pages
Global

From

€2286EUR$2,500USD£1,946GBP

Bone Cancer Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

Intratumoral Cancer Therapies Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

Solid Tumor Cancer Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

2,091 Results (Page 84 of 105)
- 1
- 82
- 83
- 84
- 85
- 86

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.